glp-1 receptor agonists mechanism of action Frontiers GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Table 2 Clinical application studies of GLP-1 RAs in pediatric obesity
(15) After inducing diabetic osteoporosis through a high fat diet and streptozotocin, light and scanning electron microscopy revealed evidence of bone deterioration via the upregulation of nuclear factor kappa-B ligand (RANKL) and downregulation of pro-osteogenic markers OPG and osteocalcin
What is the science on how Ozempic causes vision loss
GM: Writing review and editing
W., Knauf, J
There are concerns that GLP-1 receptor agonists may perform differently in real-world settings, compared to clinical trials
